Kayihura Manigaba

Kayihura Manigaba, Pharm.D., BCIDP

Clinical Assistant Professor

Department: Pharmacy Education and Practice
Business Phone: (352) 273-8474
Business Email: manigk@ufl.edu

About Kayihura Manigaba

Dr. Kayihura Manigaba stands as an exemplar of excellence in the field of pharmacy, embodying an unwavering commitment to advancing pharmacy education, showcasing exceptional clinical proficiency, and spearheading pioneering research. With strong leadership skills at the forefront, his achievements and impact have positioned him not only as a respected educator but also as a revered leader in the field. Dr. Manigaba’s dynamic mentoring skills, coupled with his research prowess and innovative mindset, further underscore his role as a beacon of inspiration within the pharmacy community.

Dr. Manigaba embarked on his journey with the completion of his Doctor of Pharmacy degree from the prestigious University of Tennessee College of Pharmacy in Memphis, TN. This foundation led him to further elevate his expertise through an ASHP-accredited PGY-1 Pharmacy Residency and a distinguished ASHP-accredited PGY2 Residency in Infectious Diseases at UF Health Shands Hospital in Gainesville, Florida.

Dr. Kayihura Manigaba is an esteemed educator in the pharmacy doctorate program at the University of Florida, where he imparts his profound knowledge across an array of courses including Professional Practice Skills labs in the 2nd and 3rd years, as well as Patient Care 2, Patient Care 4, and Patient Care 5. His commitment to bridging theory and practice resonates deeply, serving as a cornerstone in the comprehensive development of future pharmacists.

Beyond the classroom, Dr. Manigaba’s dedication to advancing the pharmacy profession is evident. As a valued member of the Society of Infectious Diseases Pharmacists research committee, he plays an active role in evaluating and awarding research grants. This engagement underscores his commitment to driving progress within the infectious diseases field and contributing to improved patient outcomes.

As a board-certified infectious diseases pharmacist, Dr. Manigaba’s influence spans a diverse range of critical healthcare domains. His professional pursuits and research interests encompass infectious diseases, therapeutic drug monitoring, interventions for multidrug-resistant pathogens, and the pivotal area of antimicrobial stewardship.

Dr. Manigaba’s influence reaches beyond borders. His dedication to advancing healthcare has driven him to collaborate on a global scale, specifically targeting the critical issue of antimicrobial resistance. Through innovative approaches and strategic partnerships, he endeavors to make a transformative impact on healthcare systems worldwide.

Dr. Manigaba’s tenure as Clinical Pharmacy Manager underscored his exceptional leadership skills and transformative impact. Leading a team of pharmacists and physicians, he orchestrated the implementation of varied clinical services across the hospital, resulting in improved patient care. His strategic leadership extended to the Pharmacy and Therapeutics Committee, where he spearheaded best practices that not only enhanced patient care but also optimized costs. Under his guidance, the hospital earned regional distinction due to consistent surpassing of performance metrics.

In summary, Dr. Kayihura Manigaba’s journey underscores his exceptional contributions to pharmacy education, clinical proficiency, and transformative healthcare change. His role as both an esteemed educator and a visionary leader is evident through his dedication to bridging theory and practice, active involvement in committees, and impactful research engagements. Dr. Manigaba’s influence reaches beyond academia, as his global collaborations and leadership in critical healthcare domains showcase his commitment to driving positive change on a broad scale. His legacy leaves an indelible mark on the pharmacy profession, resonating through enhanced patient care and the advancement of healthcare systems worldwide.

Teaching Profile

Courses Taught
PHA5782C Patient Care 2: Introduction to Infectious Disease and Oncology
PHA5784C Pt Care 4: GI and Renal
PHA5166L Prof Skills Lab Vi
PHA5787C Pt Care 5: Endo
PHA5163L Prac Skills Lab III
PHA5164L Prof Skills Lab Iv
Teaching Philosophy
In my approach to teaching, I firmly believe that students thrive when they receive ample support, engage actively, and encounter challenges. I am honored to have received the “Best Storyteller Awards” for two consecutive years, alongside recognition for teaching excellence, stemming from my innovative teaching approach. In my pursuit of excellence, I craft a dynamic learning atmosphere where every student is acknowledged, listened to, and esteemed. Encouraging active participation in their educational journey, I initiate each class with a student check-in, establishing the session’s tone and capturing their focus before delving into the core subject matter. To enrich the learning experience, I harness a range of evidence-based instructional techniques and technologies, including interactive storytelling, real-time Q&A sessions, and engaging interactive polling. Student input is integral to my teaching, as I continually integrate their feedback into my methods, utilizing evaluations and metrics to guide the ongoing evolution of course design and delivery. A focal point of my pedagogical approach lies in meeting students at their unique junctures, considering their existing knowledge, skill levels, and emotional states. Valuing each student’s individuality, I am committed to fostering an environment that empowers them to flourish. Regularly evaluating my teaching methods and seeking opportunities for growth is essential. I analyze student feedback and assess the effectiveness of various approaches to ensure that my teaching aligns with my goals of providing an outstanding learning experience. My ultimate aim as an educator is to inspire and challenge students, equipping them with the tools they need to succeed while nurturing a lifelong love for learning. It’s an immense honor to significantly contribute to the healthcare system and our society by nurturing capable healthcare professionals who prioritize compassionate patient care.

Board Certifications

  • Board Certified Infectious Diseases Pharmacist (BCIDP)
    Board of Pharmacy Specialties

Research Profile

Dr. Kayihura Manigaba’s research profile reflects a substantial contribution to the field of healthcare, with a particular emphasis on infectious diseases and antimicrobial stewardship. His recent publications encompass a range of pertinent topics, such as the implications of COVID-19, drug interactions, therapeutic drug monitoring of antimicrobial therapy, and innovative approaches to antimicrobial therapy. Noteworthy contributions include analyses of pathogen susceptibility, innovative strategies for optimizing antibiotic usage, and practical insights into implementing effective antimicrobial stewardship, even in resource-limited settings. Dr. Manigaba’s research endeavors showcase his dedication to advancing both theoretical knowledge and practical solutions in pharmacy and healthcare, underscoring his commitment to addressing pressing healthcare challenges.


Beta-lactam target attainment and associated outcomes in patients with bloodstream infections.
International journal of antimicrobial agents. 61(3) [DOI] 10.1016/j.ijantimicag.2023.106727. [PMID] 36646230.
Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling.
Critical care explorations. 5(11) [DOI] 10.1097/CCE.0000000000000993. [PMID] 38304706.
Implementing Antimicrobial Stewardship in Sub-Saharan Africa: Challenges, Progress, and Solutions.
ACCP Global Health PRN. 6-8
A waterfall of susceptibility results: impact of microbiology testing cascade for MDROs.
Diagnostic microbiology and infectious disease. 104(1) [DOI] 10.1016/j.diagmicrobio.2022.115731. [PMID] 35841735.
A new frontier: navigating hospital pharmacy practice during the COVID-19 pandemic.
Journal of Research in Pharmacy. 25(6)
COVID-19: The Culprit, the People and Lessons Learned
HCA Healthcare Journal of Medicine . 1(4):247-250 [DOI] 10.36518/2689-0216.1093. [PMID] 37425670.
Remdesvir-warfarin interaction: A case report
HCA Healthcare Journal of Medicine. 1(COVID-19):385-389 [DOI] 10.36518/2689-0216.1164. [PMID] 37426841.
SCAN: A novel approach for vancomycin time-out.
Infection control and hospital epidemiology. 39(12):1501-1503 [DOI] 10.1017/ice.2018.249. [PMID] 30303049.
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Microbiology insights. 11 [DOI] 10.1177/1178636118804549. [PMID] 30349291.
Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
Antimicrobial agents and chemotherapy. 61(9) [DOI] 10.1128/AAC.00651-17. [PMID] 28630186.
Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.
Antimicrobial agents and chemotherapy. 59(10):5942-50 [DOI] 10.1128/AAC.01358-15. [PMID] 26169412.
Ethnic differences in DNA methyltransferases expression in patients with systemic lupus erythematosus.
Journal of clinical immunology. 33(2):342-8 [DOI] 10.1007/s10875-012-9803-z. [PMID] 23054340.


2016 · The University of Tennessee Health Science Center

Contact Details

(352) 273-8474
Business Mailing:
PO Box 100486